Skip to main content Skip to navigation
Menu
800-789-7366

Elizabeth Anne Genovese, MD, MS, FACS, RPVI

Vascular Surgery
headshot of Elizabeth Anne Genovese, MD, MS, FACS, RPVI
4.9 with 114 ratings

Sees patients age 18 and up

Elizabeth Anne Genovese, MD, MS, FACS, RPVI

Vascular Surgery
4.9 with 114 ratings

Sees patients age 18 and up

  • Program Director, Penn Advanced Limb Preservation, Hospital of the University of Pennsylvania
  • Assistant Professor of Surgery at the Hospital of the University of Pennsylvania
  • Dr. Genovese is a Penn Medicine physician.
Call 800-789-7366 Request Appointment

Meet Dr. Genovese

Dr. Elizabeth Genovese is a Board-Certified Vascular Surgeon and an Assistant Professor of Surgery at the University of Pennsylvania. Dr. Genovese is a national leader in advanced endovascular therapies for limb salvage in patients who suffer from peripheral arterial disease, serves as the principal investigator for numerous clinical trials and is the Director of the Penn Advanced Limb Preservation Program at the Hospital of the University of Pennsylvania.

 

Dr. Genovese graduated from the University of Notre Dame, attended medical school at the University of Pittsburgh, where she also earned a Master’s in Clinical Research, and completed her Vascular Surgery Residency at the University of Pittsburgh Medical Center, where she served as Chief Resident.

 

Dr. Genovese has extensive experience in both open vascular surgeries and minimally invasive, endovascular procedures for the treatment of peripheral arterial disease (PAD), cerebrovascular disease, mesenteric occlusive disease, aortic aneurysms, dialysis access and venous disease.

 

She currently serves as the Chair of the Lower Extremity Bypass modules for the Society of Vascular Surgery’s Vascular Quality Initiative and the Chair of the Research Consortium for the Vascular and Endovascular Surgical Society. Her research focuses on healthcare disparities in peripheral arterial disease detection, treatment and outcomes, along with integration of new technology to streamline treatment algorithms and improve outcomes with complex endovascular therapies for peripheral arterial disease.

Back To Top